We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Home Care by Special Nurses Benefits Cancer Patients

By HospiMedica staff writers
Posted on 27 Dec 2000
A four-year study has shown that home care by specially trained registered nurses increased the survival of elderly cancer patients by seven months. More...
Conducted by researchers at the University of Pennsylvania School of Nursing (Philadelphia, PA, USA), the results were published in the December issue of the Journal of the American School of Nursing.

The study involved 375 cancer patients newly discharged from the hospital after cancer surgery. Some patients received standard care while an experimental group received three home visits and five telephone contacts with an advanced practice nurse, who also educated family members about caregiving. Advanced practice nurses can conduct physical examinations and prescribe medication. According to the researchers, the findings were significant because the patients who received the special nursing care tended to be in later stages of their cancer than the group receiving standard care.

The study focused on elderly patients, who are more likely to experience postoperative complications. This problem is worsened by a trend to discharge patients rapidly after surgery. Interventions by an advanced practice nurse served to avert or address complications rapidly. In contrast, some patients in the standard care group died prematurely from surgical complications, such as infections. The authors speculate that survival may also have been enhanced in the experimental group by the psychosocial support that nurses gave patients and families.

"Imagine what a breakthrough it would be to find a drug that bought cancer patients seven months of high-quality time,” said Ruth McCorkle, a professor at Yale University School of Nursing and lead author of the study. "Well, we've found something that can extend life that dramatically, and it's not a drug that requires a long and expensive approval process before patients can benefit from it.”



Related Links:
University of Pennsylvania

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.